Scientific Advisory Board
These individuals review and give constructive feedback on the translational relevance, scientific rigor, track record and expertise of the investigator, proposed timeline and associated budget of the project, and overall feasibility and probabilities of the suggested research. (In addition, there are scientific consultants that volunteer to review for FAST, who we will leverage if the topic is in an area outside of the scope of members of the SAB, or there is any conflict of interest for members of the SAB.) This process is led by the chair of the Scientific Advisory Board, Dr. Barbara Bailus.
At the same time, legal teams negotiate a contract to govern the grant and any advancements that may come from the grant. If and when all is ripe and the grant is approved by the chair of the SAB, the Chief Science Officer, and the entire FAST Board of Directors, then the contract is signed and the work can begin immediately.
Anne Anderson, MD
Departments of Pediatrics and Neurology and Division of Neuroscience Baylor College of Medicine Houston, TX
Specialties: Clinical Neurophysiology, Pediatric Neurology
Joseph Anderson, Ph.D.
Associate Professor with the Gene Therapy Center at UC Davis.
Specialty: Infectious Diseases, Internal Medicine
Nadia Bahi-Buisson, PhD.
University professor and hospital practitioner in the Neuropediatrics Department of CHU Necker Enfants - Malades
Université Paris Descarte
Art Beaudet, MD
Founder and CEO of Luna Genetics
Texas Children’s Hospital
Elizabeth Berry-Kravis, Ph.D.
Rush University, Chicago, IL
Specialty: Pediatric Neurology
Lauren E. Black, Ph.D.
Charles River Laboratories Specialty: preclinical assessment of transplant drugs, oligos, monoclonals for autoimmune disease, treatment vaccines, and cell therapies
Robert Carson, Ph.D.
Vanderbilt Children’s Hospital, Nashville, TN
Specialty: Epilepsy, Pediatric Neurology
Kyle Fink, Ph.D.
Assistant Adjunct Professor
University of California, Davis Department of Neurology
Specialty: Translational research for genetically linked neurological disorders
Albert Keung, Ph.D.
Assistant Professor of Chemical and Biomolecular Engineering
NC State University
Speciality: stem cell models and molecular tools to understand epigenetic mechanisms of the human brain
Cesar Ochoa-Lubinoff, Ph.D.
Specialty: Pediatric Psychology, Pediatric Psychiatry, Developmental Behavior
University of California, Los Angeles
Bryce Reeve, Ph.D.
Professor in Population Health Sciences
Speciality: Health Measurement and Health Services Research
David Segal, Ph.D.
UC Davis School of Medicine
UC Davis Genome Center, Department of Biochemistry and Molecular Medicine, Pharmacology, MIND Institute, Specialty: Genomic therapeutics
Keith Sutton, Ph.D.
Director of pre-clinical development
Ashley Winslow, Ph.D.
Chief Science Officer, Odylia Therapeutics
Specialty: Gene Therapy and Clinical Development